A Multi Marker Evaluation of Cardiovascular Disease Risk in Patients with Rheumatoid Arthritis
Journal Title: International Journal of Clinical Biochemistry and Research - Year 2017, Vol 4, Issue 2
Abstract
Background: Rheumatoid arthritis (RA), an inflammatory joint disease, is also associated with systemic effects. Patients with RA have an increased risk of morbidity and mortality that is mainly attributable to cardiovascular disease (CVD). Both traditional and novel risk factors are implicated in causing the increased CVD risk in RA patients. Materials and Method: Forty six RA patients, diagnosed with RA as per 1987 revised ARA criteria and forty six age and sex matched healthy controls were studied. Fasting lipid profile (Total cholesterol, triglycerides, HDL cholesterol), inflammatory markers (high sensitivity C reactive protein [hsCRP] and fibrinogen), oxidant and antioxidant markers (malondialdehyde [MDA] and ferric reducing ability of plasma [FRAP]), uric acid, homocysteine and Nitric oxide (NO) were measured in all subjects. Results: Among the traditional lipid parameters studied, triglycerides were increased in RA patients compared to controls (p=0.023). Both hsCRP (p<0.001) and fibrinogen (p=0.006) were elevated in RA patients than in controls. MDA levels were increased (p<0.001) and FRAP levels decreased (p<0.001) in patients with RA compared to controls. Uric acid and homocysteine levels showed no significant difference between RA patients and controls. Nitric oxide levels were increased in RA patients when compared with controls (p=0.030). Conclusion: Patients with rheumatoid arthritis were found to have an increased risk of CVD as evidenced by increased triglyceride levels, increased inflammatory markers, presence of oxidative stress. Hence, management of these patients should also include evaluation of CVD risk besides treatment of joint symptoms.
Authors and Affiliations
Krishna Barla, Kiranmayi S. Vinapamula, Siddhartha kumar Bhattaram, Aparna R. Bitla, Suchitra M. Manohar
Keywords
Related Articles
- EP ID EP296818
- DOI 10.18231/2394-6377.2017.0033
- Views 62
- Downloads 0
Study of fibro Q test, AAR & APRI indices as markers of fibrosis in chronic liver disease
Introduction: Liver biopsy and ultrasound are the gold standard methods to assess liver fibrosis in chronic liver disease (CLD). Recently Fibrosis Quotient test (Fibro Q test), AST: ALT Ratio (AAR) & AST: Platelet Ratio...
Biochemical markers for early detection of cardiovascular disease in smokers
Introduction: The prevalence of coronary heart disease (CHD) is increasing in urban as well as rural areas in India especially during the last decade due to adoption of smoking habits. Tobacco smoking is currently ranked...
Evaluation of Serum Adenosine Deaminase (ADA) Values for Detection of Pulmonary and Extra-pulmonary Tuberculosis
Introduction: There is need of precise and faster diagnosis for pulmonary (PTB) and extra-pulmonary tuberculosis (EPTB). Accordingly, there develops a considerable interest in the development of tests based on biochemica...
A study comparing values of serum sodium estimated by colorimetric kit method with those obtained by direct and indirect ion selective electrode methods
Introduction Electrolyte abnormalities are known to cause significant morbidity and mortality when it is not detected Dyselectrolytemias are usually treatable Hyponatremia is a common manifestation encountered in the eld...
Analysis of serum ferritin levels in non-diabetic, prediabetic and diabetic individuals
Introduction: Type 2 diabetes mellitus (T2DM) is characterized by impaired insulin secretion, insulin resistance or both. In the initial asymptomatic phase there is hyperinsulinemia, as insulin resistance progress and be...